User profiles for "author:Oriol Grau-Rivera"
Oriol Grau RiveraNeurologist and investigator, BarcelonaBeta Brain Research Center Verified email at barcelonabeta.org Cited by 2615 |
[HTML][HTML] Dementia prevention in memory clinics: recommendations from the European task force for brain health services
Observational population studies indicate that prevention of dementia and cognitive decline
is being accomplished, possibly as an unintended result of better vascular prevention and …
is being accomplished, possibly as an unintended result of better vascular prevention and …
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer's continuum when only subtle changes in Aβ …
In Alzheimer's disease (AD), tau phosphorylation in the brain and its subsequent release
into cerebrospinal fluid (CSF) and blood is a dynamic process that changes during disease …
into cerebrospinal fluid (CSF) and blood is a dynamic process that changes during disease …
Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview
C Delaby, CE Teunissen, K Blennow… - Alzheimer's & …, 2022 - Wiley Online Library
Introduction The current practice of quantifying cerebrospinal fluid (CSF) biomarkers as an
aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same …
aid in the diagnosis of Alzheimer's disease (AD) varies from center to center. For a same …
Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum
M Milà‐Alomà, G Salvadó, JD Gispert… - Alzheimer's & …, 2020 - Wiley Online Library
Introduction The biological pathways involved in the preclinical stage of the Alzheimer's
continuum are not well understood. Methods We used NeuroToolKit and Elecsys® …
continuum are not well understood. Methods We used NeuroToolKit and Elecsys® …
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
D Bergeron, ML Gorno‐Tempini… - Annals of …, 2018 - Wiley Online Library
Objective To estimate the prevalence of amyloid positivity, defined by positron emission
tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological …
tomography (PET)/cerebrospinal fluid (CSF) biomarkers and/or neuropathological …
Plasma and CSF biomarkers in a memory clinic: head‐to‐head comparison of phosphorylated tau immunoassays
NJ Ashton, A Puig‐Pijoan, M Milà‐Alomà… - Alzheimer's & …, 2023 - Wiley Online Library
Introduction Direct comparisons of the main blood phosphorylated tau immunoassays in
memory clinic populations are needed to understand possible differences. Methods In the …
memory clinic populations are needed to understand possible differences. Methods In the …
Clinicopathological correlations and concomitant pathologies in rapidly progressive dementia: a brain bank series
O Grau-Rivera, E Gelpi, C Nos, C Gaig… - Neurodegenerative …, 2015 - karger.com
Background: Rapidly progressive dementia (RPD) is caused by a heterogeneous group of
both neurodegenerative and non-neurodegenerative disorders. The presence of …
both neurodegenerative and non-neurodegenerative disorders. The presence of …
[HTML][HTML] Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
G Salvadó, JL Molinuevo, A Brugulat-Serrat… - Alzheimer's research & …, 2019 - Springer
Abstract Background The Centiloid scale has been developed to standardize measurements
of amyloid PET imaging. Reference cut-off values of this continuous measurement enable …
of amyloid PET imaging. Reference cut-off values of this continuous measurement enable …
[HTML][HTML] Associations between air pollution and biomarkers of Alzheimer's disease in cognitively unimpaired individuals
S Alemany, M Crous-Bou, N Vilor-Tejedor… - Environment …, 2021 - Elsevier
Background Air quality contributes to incidence of Alzheimer's disease (AD) although the
underlying neurobiological mechanisms are unclear. This study was aimed to examine the …
underlying neurobiological mechanisms are unclear. This study was aimed to examine the …
[HTML][HTML] A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer's disease
J Verheijen, T Van den Bossche, J van der Zee… - Acta …, 2016 - Springer
The sortilin-related receptor 1 (SORL1) gene has been associated with increased risk for
Alzheimer's disease (AD). Rare genetic variants in the SORL1 gene have also been …
Alzheimer's disease (AD). Rare genetic variants in the SORL1 gene have also been …